The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia


Por: Diaz-Beya, M, Brunet, S, Nomdedeu, J, Cordeiro, A, Tormo, M, Escoda, L, Ribera, JM, Arnan, M, Heras, I, Gallardo, D, Bargay, J, de Llano, MPQ, Salamero, O, Marti, JM, Sampol, A, Pedro, C, Hoyos, M, Pratcorona, M, Castellano, JJ, Nomdedeu, M, Risueno, RM, Sierra, J, Monzo, M, Navarro, A, Esteve, J

Publicada: 1 oct 2015
Resumen:
Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular profiling. In elderly patients (>= 60 years) with normal karyotype AML miR-3151 have been identified as a prognostic factor. However, miR-3151 prognostic value has not been examined in younger AML patients. In the present work, we have studied miR-3151 alone and in combination with BAALC, its host gene, in a cohort of 181 younger intermediate-risk AML (IR-AML) patients. Patients with higher expression of miR-3151 had shorter overall survival (P = 0.0025), shorter leukemia-free survival (P = 0.026) and higher cumulative incidence of relapse (P = 0.082). Moreover, in the multivariate analysis miR-3151 emerged as independent prognostic marker in both the overall series and within the unfavorable molecular prognostic category. Interestingly, the combined determination of both miR-3151 and BAALC improved this prognostic stratification, with patients with low levels of both parameters showing a better outcome compared with those patients harboring increased levels of one or both markers (P = 0.003). In addition, we studied the microRNA expression profile associated with miR-3151 identifying a six-microRNA signature. In conclusion, the analysis of miR-3151 and BAALC expression may well contribute to an improved prognostic stratification of younger patients with IR-AML.

Filiaciones:
Diaz-Beya, M:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

Brunet, S:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Dept Hematol, E-08193 Barcelona, Spain

 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Biol Hematol Lab, E-08193 Barcelona, Spain

Nomdedeu, J:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Dept Hematol, E-08193 Barcelona, Spain

 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Biol Hematol Lab, E-08193 Barcelona, Spain

Cordeiro, A:
 Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med, Barcelona, Spain

Tormo, M:
 Hosp Clin, Dept Hematol, Valencia, Spain

Escoda, L:
 Hosp Joan 23, Dept Hematol, Tarragona, Spain

Ribera, JM:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

 Hosp Badalona Germans Trias & Pujol, ICO, Hematol Dept, Badalona, Spain

Arnan, M:
 Hosp Duran & Reynals, Dept Hematol, ICO, Barcelona, Spain

Heras, I:
 Hosp Morales Meseguer, Dept Hematol, Murcia, Spain

Gallardo, D:
 ICO Josep Trueta, Dept Hematol, Girona, Spain

Bargay, J:
 Hosp Son Llatzer, Dept Hematol, Palma de Mallorca Hematol, Palma De Mallorca, Spain

de Llano, MPQ:
 Hosp Virgen de la Victoria, Dept Hematol, Malaga, Spain

Salamero, O:
 Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain

Marti, JM:
 Hosp Mutua de Terrassa, Dept Hematol, Barcelona, Spain

Sampol, A:
 Hosp Son Llatzer, Dept Hematol, Palma Of Mallorca, Spain

Pedro, C:
 Hosp Mar, Dept Hematol, Barcelona, Spain

Hoyos, M:
 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Dept Hematol, E-08193 Barcelona, Spain

 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Biol Hematol Lab, E-08193 Barcelona, Spain

Pratcorona, M:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

Castellano, JJ:
 Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med, Barcelona, Spain

Nomdedeu, M:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

Risueno, RM:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

Sierra, J:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Dept Hematol, E-08193 Barcelona, Spain

 Univ Autonoma Barcelona, IIB St Pau Res Inst, Hosp St Pau, Biol Hematol Lab, E-08193 Barcelona, Spain

Monzo, M:
 Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med, Barcelona, Spain

Navarro, A:
 Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med, Barcelona, Spain

Esteve, J:
 Josep Carreras Leukaemia Res Inst, Barcelona, Spain

 Univ Barcelona, Barcelona, Spain
ISSN: 20445385
Editorial
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 5 Número:
Páginas:
WOS Id: 000368920300002
ID de PubMed: 26430723
imagen Gold, Green Published

MÉTRICAS